Literature DB >> 26181189

Combination Immunotherapy for Melanoma.

Howard L Kaufman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26181189     DOI： 10.1001/jamaoncol.2015.0479

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  2 in total

Review 1.  Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies.

Authors:  Ingrid Lilienthal; Nikolas Herold
Journal:  Int J Mol Sci       Date:  2020-09-19       Impact factor: 5.923

2.  Interferon-γ and Tumor Necrosis Factor-α Polarize Bone Marrow Stromal Cells Uniformly to a Th1 Phenotype.

Authors:  Ping Jin; Yuanlong Zhao; Hui Liu; Jinguo Chen; Jiaqiang Ren; Jianjian Jin; Davide Bedognetti; Shutong Liu; Ena Wang; Francesco Marincola; David Stroncek
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.